48
Participants
Start Date
February 17, 2020
Primary Completion Date
January 19, 2022
Study Completion Date
January 19, 2022
OLP treatment
Receive two open-label placebo pills twice a day after randomization. Will receive for 21 days and then stop. It will include educational materials and positive expectancy.
Usual care
Remain in standard care after randomization and educational materials.
Expectancy Group
Educational materials and positive expectancy orientation via Zoom or telephone
Tanner Foundation, Birmingham
University of Alabama at Birmingham, Birmingham
University of Alabama at Birmingham
OTHER